These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7630864)

  • 1. Particular outcomes of myocardial ischaemia: stunning and hibernation.
    Ferrari R; Visioli O
    Pharmacol Res; 1995; 31(3-4):235-41. PubMed ID: 7630864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stunned and hibernating myocardium: possibility of intervention.
    Ferrari R; La Canna G; Giubbini R; Visioli O
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation.
    Ferrari R; Ceconi C; Curello S; Benigno M; La Canna G; Pepi P; Ferrari F; Visioli O
    Int J Cardiol; 1998 May; 65 Suppl 1():S7-16. PubMed ID: 9706821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
    Ferrari R; Ceconi C; Curello S; Benigno M; La Canna G; Visioli O
    J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S18-26. PubMed ID: 8891867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hibernating myocardium: a review.
    Heusch G; Schulz R
    J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hibernating myocardium].
    Kirkebøen KA
    Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1934-8. PubMed ID: 7638844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stunning: damaging or protective to the myocardium?
    Ferrari R; Visioli O
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):939-45. PubMed ID: 1756141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hibernating and stunned myocardium.
    Heusch G; Schulz R
    Eur Heart J; 1997 Jun; 18 Suppl D():D102-10. PubMed ID: 9183618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of short-term myocardial hibernation.
    Heusch G; Schulz R
    Mol Cell Biochem; 1998 Sep; 186(1-2):185-93. PubMed ID: 9774200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three cardiac mysteries--stunning, hibernation and ischemic preconditioning].
    Grund F
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):440-4. PubMed ID: 11255859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial viability.
    Birnbaum Y; Kloner RA
    West J Med; 1996 Dec; 165(6):364-71. PubMed ID: 9000857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular dysfunction due to stunning and hibernation in patients.
    Ferrari R; La Canna G; Giubbini R; Milan E; Ceconi C; de Giuli F; Berra P; Alfieri O; Visioli O
    Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():371-80. PubMed ID: 7947380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disturbances during myocardial ischemia and reperfusion.
    Ferrari R
    Am J Cardiol; 1995 Aug; 76(6):17B-24B. PubMed ID: 7645523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
    Sokolova RI; Zhdanov VS
    Kardiologiia; 2005; 45(9):73-8. PubMed ID: 16234797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial hibernation vs repetitive stunning in patients.
    Camici PG; Rimoldi O
    Cardiol Rev; 1999; 7(1):39-43. PubMed ID: 10348965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.